206 related articles for article (PubMed ID: 11502522)
21. Development of a human immunodeficiency virus vector-based, single-cycle assay for evaluation of anti-integrase compounds.
Bona R; Andreotti M; Buffa V; Leone P; Galluzzo CM; Amici R; Palmisano L; Mancini MG; Michelini Z; Di Santo R; Costi R; Roux A; Pommier Y; Marchand C; Vella S; Cara A
Antimicrob Agents Chemother; 2006 Oct; 50(10):3407-17. PubMed ID: 17005823
[TBL] [Abstract][Full Text] [Related]
22. New class of HIV integrase inhibitors that block viral replication in cell culture.
Pannecouque C; Pluymers W; Van Maele B; Tetz V; Cherepanov P; De Clercq E; Witvrouw M; Debyser Z
Curr Biol; 2002 Jul; 12(14):1169-77. PubMed ID: 12176326
[TBL] [Abstract][Full Text] [Related]
23. In search of authentic inhibitors of HIV-1 integration.
Debyser Z; Cherepanov P; Van Maele B; De Clercq E; Witvrouw M
Antivir Chem Chemother; 2002 Jan; 13(1):1-15. PubMed ID: 12180645
[TBL] [Abstract][Full Text] [Related]
24. Modulation of HIV-1 integrase activity by single-stranded oligonucleotides and their conjugates with eosin.
Korolev S; Knyazhanskaya E; Anisenko A; Tashlitskii V; Zatsepin TS; Gottikh M; Agapkina J
Nucleosides Nucleotides Nucleic Acids; 2011; 30(7-8):651-66. PubMed ID: 21888554
[TBL] [Abstract][Full Text] [Related]
25. Design and development of integrase inhibitors as anti-HIV agents.
Gupta SP; Nagappa AN
Curr Med Chem; 2003 Sep; 10(18):1779-94. PubMed ID: 12871104
[TBL] [Abstract][Full Text] [Related]
26. Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore.
Kehlenbeck S; Betz U; Birkmann A; Fast B; Göller AH; Henninger K; Lowinger T; Marrero D; Paessens A; Paulsen D; Pevzner V; Schohe-Loop R; Tsujishita H; Welker R; Kreuter J; Rübsamen-Waigmann H; Dittmer F
J Virol; 2006 Jul; 80(14):6883-94. PubMed ID: 16809294
[TBL] [Abstract][Full Text] [Related]
27. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.
Robinson WE; Cordeiro M; Abdel-Malek S; Jia Q; Chow SA; Reinecke MG; Mitchell WM
Mol Pharmacol; 1996 Oct; 50(4):846-55. PubMed ID: 8863829
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of human immunodeficiency virus type 1 concerted integration related to strand transfer inhibition and drug resistance.
Zahm JA; Bera S; Pandey KK; Vora A; Stillmock K; Hazuda D; Grandgenett DP
Antimicrob Agents Chemother; 2008 Sep; 52(9):3358-68. PubMed ID: 18591263
[TBL] [Abstract][Full Text] [Related]
29. Structure-activity of inhibition of HIV-1 integrase and virus replication by G-quartet oligonucleotides.
Jing N; Marchand C; Guan Y; Liu J; Pallansch L; Lackman-Smith C; De Clercq E; Pommier Y
DNA Cell Biol; 2001 Aug; 20(8):499-508. PubMed ID: 11560782
[TBL] [Abstract][Full Text] [Related]
30. Lamellarin alpha 20-sulfate, an inhibitor of HIV-1 integrase active against HIV-1 virus in cell culture.
Reddy MV; Rao MR; Rhodes D; Hansen MS; Rubins K; Bushman FD; Venkateswarlu Y; Faulkner DJ
J Med Chem; 1999 Jun; 42(11):1901-7. PubMed ID: 10354398
[TBL] [Abstract][Full Text] [Related]
31. The use of a new in vitro reaction substrate reproducing both U3 and U5 regions of the HIV-1 3'-ends increases the correlation between the in vitro and in vivo effects of the HIV-1 integrase inhibitors.
Tramontano E; Onidi L; Esposito F; Badas R; La Colla P
Biochem Pharmacol; 2004 May; 67(9):1751-61. PubMed ID: 15081874
[TBL] [Abstract][Full Text] [Related]
32. Diketoacid inhibitors of HIV-1 integrase: from L-708,906 to raltegravir and beyond.
Beare KD; Coster MJ; Rutledge PJ
Curr Med Chem; 2012; 19(8):1177-92. PubMed ID: 22214459
[TBL] [Abstract][Full Text] [Related]
33. A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase.
Hazuda DJ; Anthony NJ; Gomez RP; Jolly SM; Wai JS; Zhuang L; Fisher TE; Embrey M; Guare JP; Egbertson MS; Vacca JP; Huff JR; Felock PJ; Witmer MV; Stillmock KA; Danovich R; Grobler J; Miller MD; Espeseth AS; Jin L; Chen IW; Lin JH; Kassahun K; Ellis JD; Wong BK; Xu W; Pearson PG; Schleif WA; Cortese R; Emini E; Summa V; Holloway MK; Young SD
Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11233-8. PubMed ID: 15277684
[TBL] [Abstract][Full Text] [Related]
34. DNA aptamers derived from HIV-1 RNase H inhibitors are strong anti-integrase agents.
de Soultrait VR; Lozach PY; Altmeyer R; Tarrago-Litvak L; Litvak S; Andréola ML
J Mol Biol; 2002 Nov; 324(2):195-203. PubMed ID: 12441099
[TBL] [Abstract][Full Text] [Related]
35. Effect of DNA modifications on DNA processing by HIV-1 integrase and inhibitor binding: role of DNA backbone flexibility and an open catalytic site.
Johnson AA; Sayer JM; Yagi H; Patil SS; Debart F; Maier MA; Corey DR; Vasseur JJ; Burke TR; Marquez VE; Jerina DM; Pommier Y
J Biol Chem; 2006 Oct; 281(43):32428-38. PubMed ID: 16943199
[TBL] [Abstract][Full Text] [Related]
36. Closely related antiretroviral agents as inhibitors of two HIV-1 enzymes, ribonuclease H and integrase: "killing two birds with one stone".
Andréola ML
Curr Pharm Des; 2004; 10(30):3713-23. PubMed ID: 15579066
[TBL] [Abstract][Full Text] [Related]
37. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
Neamati N; Hong H; Owen JM; Sunder S; Winslow HE; Christensen JL; Zhao H; Burke TR; Milne GW; Pommier Y
J Med Chem; 1998 Aug; 41(17):3202-9. PubMed ID: 9703465
[TBL] [Abstract][Full Text] [Related]
38. L-chicoric acid inhibits human immunodeficiency virus type 1 integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitro.
Reinke RA; Lee DJ; McDougall BR; King PJ; Victoria J; Mao Y; Lei X; Reinecke MG; Robinson WE
Virology; 2004 Sep; 326(2):203-19. PubMed ID: 15302207
[TBL] [Abstract][Full Text] [Related]
39. Irreversible inhibition of human immunodeficiency virus type 1 integrase by dicaffeoylquinic acids.
Zhu K; Cordeiro ML; Atienza J; Robinson WE; Chow SA
J Virol; 1999 Apr; 73(4):3309-16. PubMed ID: 10074185
[TBL] [Abstract][Full Text] [Related]
40. Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters.
Pluymers W; Neamati N; Pannecouque C; Fikkert V; Marchand C; Burke TR; Pommier Y; Schols D; De Clercq E; Debyser Z; Witvrouw M
Mol Pharmacol; 2000 Sep; 58(3):641-8. PubMed ID: 10953059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]